How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician- and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register

Rheumatology

Volumn 50, Issue 1, 2011, Pages 152-160

  Gäwert, Lotta ^a   Hierse, Franka ^a   Zink, Angela ^a,b   Strangfeld, Anja ^a  

^a German Natl Research Cent for   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adverse events; Biologics registers; Drug monitoring; Drug safety; Patients' role; Pharmacovigilance

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ALOPECIA; ARTICLE; COMORBIDITY; DISEASE REGISTRY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL DISEASE; GERMAN BIOLOGICS REGISTER; GOLD STANDARD; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; REGISTER; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SELF REPORT; UNSPECIFIED SIDE EFFECT; VALIDITY;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; DATA COLLECTION; DRUG TOXICITY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PATIENTS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; REGISTRIES; SELF REPORT;

EID: 79951719437     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq300     Document Type: Article

References (22)

1. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006;29:385-96.
2. World Health Organization. Safety of medicines - a guide to detecting and reporting of adverse drug reactions. Why health professionals need to take action. Geneva: WHO, 2002.
3. Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Pharmacoepidemiol Drug Saf 2009;18:240-5.
4. van HF, Passier A, van GK. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol 2009;67:558-64.
5. Medicines and healthcare products regulatory agency. 2010. http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Medicines/Reportingsuspectedadversedrugreactions/Patientreporting/index.htm (27 August 2010, date last accessed).
6. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007;63:148-56.
7. van GK, de Jong-van den Berg. Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 2004;3: 363-8.
8. Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP. European Biologics Registers - methodology, selected results, and perspectives. Ann Rheum Dis Advance Access published 22 July 2008, doi:10.1136/ard.2008.091926.
9. Listing J, Strangfeld A, Kary S et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005;52:3403-12.
10. Strangfeld A, Listing J, Herzer P et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009;301:737-44.
11. MedDRA Maintenance and Support Services Organization. Northrop Grumman Corporation, McLean, Virginia, USA. 2010. http://www.meddramsso.com (27 August 2010, date last accessed).
12. European Medicines Agency. Clinical safety data management: definitions and standards for expedited reporting. 2010. http://www.emea.europa.eu/pdfs/human/ich/037795en.pdf (27 August 2010, date last accessed).
13. de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008;31:515-24.
14. Egberts TC, Smulders M, de Koning FH, Meyboom RH, Leufkens HG. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. Br Med J 1996;313:530-1.
15. Cirillo M, Venturini M, Ciccarelli L, Coati F, Bortolami O, Verlato G. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire. Ann Oncol 2009;20: 1929-35.
16. Basch E, Jia X, Heller G et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 2009;101: 1624-32.
17. van den Bemt PM, Egberts AC, Lenderink AW et al. Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol 1999;55:155-8.
18. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 2004;22:3485-90.
19. Basch E, Iasonos A, McDonough T et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 2006;7:903-9.
20. Repping-Wuts H, Uitterhoeve R, Van RP, van AT. Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 2008;45: 995-1002.
21. Zink A, Strangfeld A, Schneider M et al. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. Arthritis Rheum 2006;54: 3399-407.
22. Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med 2006;144: 257-61.